Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer
Abstract Serine peptidase inhibitor, Kazal type 1 (SPINK1), a 56-amino-acid protein in its mature form, was among the first pancreatic enzymes to be extensively characterized biochemically and functionally. Synthesized primarily in pancreatic acinar cells and traditionally known as pancreatic secret...
Saved in:
| Main Authors: | Qi-Wen Wang, Wen-Bin Zou, Emmanuelle Masson, Claude Férec, Zhuan Liao, Jian-Min Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Human Genomics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40246-025-00740-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary: An insight to PDAC tumor heterogeneity across pancreatic subregions using computed tomography images
by: Jiandong Cao, et al.
Published: (2025-04-01) -
Obesity reprograms the normal pancreas and pancreatic cancer microbiome in mice and humans
by: Raquel Santana da Cruz, et al.
Published: (2025-07-01) -
Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
by: Seiji Nakahara, et al.
Published: (2023-08-01) -
Upregulation of Lactobacillus spp. in gut microbiota as a novel mechanism for environmental eustress-induced anti-pancreatic cancer effects
by: Yiyi Liang, et al.
Published: (2025-12-01) -
Should every patient with pancreatic cancer receive perioperative/neoadjuvant therapy?
by: Ulrich Nitsche, et al.
Published: (2016-01-01)